CLRB — Cellectar Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Cellectar Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	57.2	35.7	19.9	9.56	23.3
Prepaid Expenses
Total Current Assets	57.9	36.6	20.5	10.5	24.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.638	0.549	0.979	1.59	1.19
Other Long Term Assets
Total Assets	58.7	37.2	21.6	12.1	25.5
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.56	3.99	5.53	12.9	9.39
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.86	4.16	6.08	13.4	9.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	54.8	33	15.5	-1.36	15.7
Total Liabilities & Shareholders' Equity	58.7	37.2	21.6	12.1	25.5
Total Common Shares Outstanding
Total Preferred Shares Outstanding